Lates News

Elon Musk's brain-computer interface company Neuralink is expected to reach revenues of $1 billion by 2030 with significant expansion. The company hopes to implant chips in the brains of 20,000 people annually by 2031. It is anticipated to receive initial approval from the U.S. Food and Drug Administration by 2029. The company plans to offer "deep" devices to patients with tumors and Parkinson's disease.